Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events (ADANCE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by Xijing Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Xijing Hospital
ClinicalTrials.gov Identifier:
NCT01924325
First received: August 13, 2013
Last updated: NA
Last verified: August 2013
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)